Australia
· Delayed Price · Currency is AUD Botanix Pharmaceuticals Statistics
Total Valuation
ASX:BOT has a market cap or net worth of AUD 769.75 million. The enterprise value is 722.18 million.
| Market Cap | 769.75M |
| Enterprise Value | 722.18M |
Important Dates
The next estimated earnings date is Monday, May 26, 2025.
| Earnings Date | May 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:BOT has 1.83 billion shares outstanding. The number of shares has increased by 24.08% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.83B |
| Shares Change (YoY) | +24.08% |
| Shares Change (QoQ) | +16.14% |
| Owned by Insiders (%) | 9.97% |
| Owned by Institutions (%) | 12.51% |
| Float | 1.59B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 372.01 |
| PB Ratio | 8.32 |
| P/TBV Ratio | 12.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.38 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.58 |
Financial Position
The company has a current ratio of 10.63, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.63 |
| Quick Ratio | 7.72 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -1,061.12 |
Financial Efficiency
Return on equity (ROE) is -56.99% and return on invested capital (ROIC) is -36.43%.
| Return on Equity (ROE) | -56.99% |
| Return on Assets (ROA) | -34.36% |
| Return on Invested Capital (ROIC) | -36.43% |
| Return on Capital Employed (ROCE) | -43.45% |
| Revenue Per Employee | 188,105 |
| Profits Per Employee | -3.57M |
| Employee Count | 11 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +95.35% in the last 52 weeks. The beta is 1.27, so ASX:BOT's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +95.35% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 54.62 |
| Average Volume (20 Days) | 10,034,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:BOT had revenue of AUD 2.07 million and -39.29 million in losses. Loss per share was -0.02.
| Revenue | 2.07M |
| Gross Profit | -1.81M |
| Operating Income | -40.44M |
| Pretax Income | -39.29M |
| Net Income | -39.29M |
| EBITDA | -39.25M |
| EBIT | -40.44M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 48.44 million in cash and 866,350 in debt, giving a net cash position of 47.57 million or 0.03 per share.
| Cash & Cash Equivalents | 48.44M |
| Total Debt | 866,350 |
| Net Cash | 47.57M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 92.49M |
| Book Value Per Share | 0.05 |
| Working Capital | 61.42M |
Cash Flow
In the last 12 months, operating cash flow was -34.93 million and capital expenditures -167,054, giving a free cash flow of -35.10 million.
| Operating Cash Flow | -34.93M |
| Capital Expenditures | -167,054 |
| Free Cash Flow | -35.10M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | -87.64% |
| Operating Margin | -1,954.28% |
| Pretax Margin | -1,898.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:BOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.08% |
| Shareholder Yield | -24.08% |
| Earnings Yield | -5.10% |
| FCF Yield | -4.56% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:BOT has an Altman Z-Score of 41.89.
| Altman Z-Score | 41.89 |
| Piotroski F-Score | n/a |